Oregon Bioscience Association

Bio-Sensor Day, Bio-Entrepreneurship, Commercialization And Industry Inflection To Highlight 2014 Conference

The Sept. 15-17 event will feature internationally known guest speakers from companies such as 23andme, the Fogarty Institute for Innovation, Translational Genomic Institute, Lawrence Livermore National Laboratories and the BioDesign Institute to showcase local innovation stories, emerging translational therapy investment opportunities and national bioscience trends. Early discounted registration ends Aug. 31.

'Oregon Bio 2014: An Industry Inflection Point' is the theme of the Oregon Bioscience Association's 2014 annual conference, which launches on Monday, September 15 and continues through Wednesday, Sept.

Where Does Oregon Rank in the Innovation Economy?

How Oregon Can Win in the New Global Innovation Economy: 2014 State New Economy Index Ranking State Competitiveness Will Be Released Wednesday, June 11 in Portland

Is Oregon leading or falling behind the new innovation economy? From biotechnology to green energy, Oregon looks to lead on the new technologies that will be central to economic growth during the next century.

Practitioners, Prescribers and Patient Advocates Call on Oregon Legislature For Improved Medication Therapy Management

The Arizona Journal of Pharmacy’s Winter 2014 issue notes that across the U.S., “poor medication adherence leads to poorer health, more frequent hospitalizations, higher risk of death and costs our medical system as much as $290 billion each year.” Here in Oregon, providers, pharmacists, and patient groups are addressing this growing issue by bringing forth legislation to help all Oregon patients better manage their medications. Medicare Part D plans starting doing this in January.

Physicians, providers, patients and groups are asking the Oregon Legislature to pass Senate Bill 1579, the “Medication Synchronization” bill. This simple legislation allows patients to synchronize their medicati

Practitioners, Prescribers AND Patient Advocates Call on Oregon Legislature for Improved Medication Therapy Management

The Lund Report
The Arizona Journal of Pharmacy’s Winter 2014 issue notes that across the U.S., “poor medication adherence leads to poorer health, more frequent hospitalizations, higher risk of death and costs our medical system as much as $290 billion each year.” Here in Oregon, providers, pharmacists, and patient groups are addressing this growing issue by bringing forth legislation to help all Oregon patients better manage their medications. Medicare Part D plans starting doing this in January.

Physicians, providers, patients and groups are asking the Oregon Legislature to pass Senate Bill 1579, the “Medication Synchronization” bill.  This simple legislation allows patients to synchroni

Oregon's ‘Father of Invention’ Honored in First Ever Bio Lifetime Achievement Award

The Lund Report
The Oregon Bioscience Association on Tuesday night honored one of Oregon’s best known inventors, cardiovascular surgeon Albert Starr, M.D., with its inaugural Lifetime Achievement Award and listened to him talk about his ‘cherry blossom moment.’
September 18, 2013 -- Well known inventor, Dr. Albert Starr, signed over this first patent, for the first model of an artificial heart valve, to his partner, James Edwards, of Edwards Laboratories.  It’s part of the legacy story of Dr. Starr’s world-changing invention; a story that includes his personal ‘cherry blossom moment.’

 

Portland’s Mayoral Candidates Speak out about Bioscience Industry’s Growth and Support

The Lund Report
Candidates Charlie Hales and Jefferson Smith share candidly about the expanding sector of bioscience in metro Portland and statewide

September 21, 2012 -- The job description for Portland, Oregon’s next mayor is clearly economic development, at least that’s where the current two mayoral candidates, Charlie Hales and Jefferson Smith, agree. The candidates also agree in prioritizing access to capital and incentives to grow investments in the sector. However, they differ in how to make that happen.

Continued Growth in Oregon’s Bioscience Industry Again Cited by International Bio

Oregon continues as a high growth state, gaining in employment, wages and establishments, according to the world’s leading organization for biotechnology and life sciences, the Biotechnology Industry Organization (BIO)

July 16, 2012 -- After three years of a downward recessionary impact on the bioscience industry across the U.S., Oregon kept an overall positive pace in employment growth and wage gains in the biotechnology and life science sectors, according to the BIO/Batelle State Bioscience Industry Development 2012 Report released last week. The Oregon Bioscience Association (Oregon Bio) established the same pattern in its local economic impact review.

Subscribe to Oregon Bioscience Association